title: Advances in follicular lymphoma.
abstract: Follicular lymphoma is a usually indolent lymphoma that responds well to chemotherapy. While multiple treatments show a good response rate, most patients relapse. Emerging therapies, such as antibody therapy and stem cell transplantation, are increasingly being used to try to lengthen response time. This article will review the available treatments for follicular lymphoma and discuss the studies supporting newer strategies of treatment.
authors.affiliation: Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198-7860, USA.
authors.forename: Travis D
authors.initials: TD
authors.lastname: Archuleta
authors.forename: James O
authors.initials: JO
authors.lastname: Armitage
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use; D008224:Lymphoma, Follicular / Q000628:therapy*; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D033581:Stem Cell Transplantation
chemical_list: D000911:Antibodies, Monoclonal; D019496:Cancer Vaccines; D018796:Immunoconjugates; D016376:Oligonucleotides, Antisense; D011480:Protease Inhibitors; D007372:Interferons